These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34510246)

  • 21. Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs.
    Pereira JB; Cavallin L; Spulber G; Aguilar C; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Aarsland D; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2014 Mar; 275(3):317-30. PubMed ID: 24118559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.
    Scheltens P; Leys D; Barkhof F; Huglo D; Weinstein HC; Vermersch P; Kuiper M; Steinling M; Wolters EC; Valk J
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):967-72. PubMed ID: 1431963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overtime reliability of medial temporal lobe atrophy rating in a clinical setting.
    Cavallin L; Løken K; Engedal K; Oksengård AR; Wahlund LO; Bronge L; Axelsson R
    Acta Radiol; 2012 Apr; 53(3):318-23. PubMed ID: 22371624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation and clinical correlation of practical cut-offs for visual rating scales of atrophy: normal aging versus mild cognitive impairment and Alzheimer's disease.
    Vanhoenacker AS; Sneyers B; De Keyzer F; Heye S; Demaerel P
    Acta Neurol Belg; 2017 Sep; 117(3):661-669. PubMed ID: 28397182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medial temporal atrophy in preclinical dementia: Visual and automated assessment during six year follow-up.
    Mårtensson G; Håkansson C; Pereira JB; Palmqvist S; Hansson O; van Westen D; Westman E
    Neuroimage Clin; 2020; 27():102310. PubMed ID: 32580125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease.
    van de Pol LA; Hensel A; van der Flier WM; Visser PJ; Pijnenburg YA; Barkhof F; Gertz HJ; Scheltens P
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):439-42. PubMed ID: 16306153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medial temporal lobe atrophy relates to executive dysfunction in Alzheimer's disease.
    Oosterman JM; Oosterveld S; Rikkert MG; Claassen JA; Kessels RP
    Int Psychogeriatr; 2012 Sep; 24(9):1474-82. PubMed ID: 22717328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medial temporal lobe atrophy in vascular dementia: visual temporal lobe rating scale.
    Cho H; Kwon JH; Seo HJ
    Arch Gerontol Geriatr; 2009; 48(3):415-8. PubMed ID: 18468705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inter-modality assessment of medial temporal lobe atrophy in a non-demented population: application of a visual rating scale template across radiologists with varying clinical experience.
    Håkansson C; Tamaddon A; Andersson H; Torisson G; Mårtensson G; Truong M; Annertz M; Londos E; Björkman-Burtscher IM; Hansson O; van Westen D
    Eur Radiol; 2022 Feb; 32(2):1127-1134. PubMed ID: 34328536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medial temporal lobe atrophy and depressive symptoms in elderly patients with and without Alzheimer disease.
    Enache D; Cavallin L; Lindberg O; Farahmand B; Kramberger MG; Westman E; Jelic V; Eriksdotter M; Ballard C; Winblad B; Wahlund LO; Aarsland D
    J Geriatr Psychiatry Neurol; 2015 Mar; 28(1):40-8. PubMed ID: 25080472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease.
    Smits LL; Tijms BM; Benedictus MR; Koedam EL; Koene T; Reuling IE; Barkhof F; Scheltens P; Pijnenburg YA; Wattjes MP; van der Flier WM
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S299-305. PubMed ID: 24210526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the Spectrum of Subcortical Hyperintensities and Cognitive Decline.
    Chen YC; Tsao HH; Chu YC; Wang JJ; Lee JD; Chang PY; Hsu WC
    J Neuropsychiatry Clin Neurosci; 2018; 30(2):130-138. PubMed ID: 29061091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual assessment of medical temporal lobe atrophy in demented and healthy control subjects: correlation with volumetry.
    Wahlund LO; Julin P; Lindqvist J; Scheltens P
    Psychiatry Res; 1999 Jun; 90(3):193-9. PubMed ID: 10466738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.
    Schoonenboom NS; van der Flier WM; Blankenstein MA; Bouwman FH; Van Kamp GJ; Barkhof F; Scheltens P
    Neurobiol Aging; 2008 May; 29(5):669-75. PubMed ID: 17208336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease.
    Staekenborg SS; Gillissen F; Romkes R; Pijnenburg YA; Barkhof F; Scheltens P; van der Flier WM
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):387-92. PubMed ID: 17907266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medial temporal lobe atrophy in Alzheimer's disease/mild cognitive impairment with depression.
    Dhikav V; Sethi M; Anand KS
    Br J Radiol; 2014 Oct; 87(1042):20140150. PubMed ID: 25061711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral small vessel disease, medial temporal lobe atrophy and cognitive status in patients with ischaemic stroke and transient ischaemic attack.
    Arba F; Quinn T; Hankey GJ; Ali M; Lees KR; Inzitari D;
    Eur J Neurol; 2017 Feb; 24(2):276-282. PubMed ID: 27862654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors.
    Appel J; Potter E; Bhatia N; Shen Q; Zhao W; Greig MT; Raj A; Barker WW; Potter H; Schofield E; Wu Y; Loewenstein DA; Duara R
    AJNR Am J Neuroradiol; 2009 Nov; 30(10):1870-6. PubMed ID: 19643919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.